The Western European consumer health industry was valued at $46.4 billion in 2022. In volume (kg) terms, the region’s sales amounted to 54.6 million kg. Western Europe’s per capita consumption of consumer health products (active nutrition protein powder and protein bars) was 0.1kg in 2022, while the per capita expenditure was $108.2. The region is forecast to record a value CAGR of 2.3% during 2022-27, which is lower than the CAGR globally as well as that for the Asia-Pacific and Americas regions.
This report brings together multiple data sources to provide a comprehensive overview of the Western Europe consumer health industry, analyzing data from 19 countries in the region. It includes analysis on the following:
Market Environment: Includes industry size, market size, and growth analysis by sectors.
High-Potential Countries Analysis: Indicates changing share of value consumption of various consumer health products by sectors across high-potential countries in Western Europe. It also provides risk-reward analysis of four countries across the region based on market assessment, economic development, sociodemographic factors, governance indicators, and technological infrastructure.
Country Deep Dive: Provides the overview, demographic analysis, and key trends across high-potential countries.
Success Stories: This section features some of the most compelling consumer health manufacturers, brands, products, and marketing campaigns in the Western European region. It also provides a better understanding of how certain manufacturers achieved success in the sector.
Competitive Environment: Provides an overview of leading companies in Western Europe, as well as analyzing the growth of private labels in the region.
Distribution Analysis: Provides analysis of the leading distribution channels in the Western European consumer health industry in 2022. It covers nine distribution channels: chemists/pharmacies, parapharmacies/drugstores, e-retailers, direct sellers, hypermarkets & supermarkets, convenience stores, cash & carries & warehouse clubs, “dollar stores”, variety stores & general merchandise retailers, other specialist retailers.
Select Industry Metrics: Provides data for alternative content including patent analytics, job analytics, and deals analytics.
Challenges and Future Outlook: Provides the challenges and outlook pertaining to the Western European consumer health industry.
This report brings together multiple data sources to provide a comprehensive overview of the Western Europe consumer health industry, analyzing data from 19 countries in the region. It includes analysis on the following:
Market Environment: Includes industry size, market size, and growth analysis by sectors.
High-Potential Countries Analysis: Indicates changing share of value consumption of various consumer health products by sectors across high-potential countries in Western Europe. It also provides risk-reward analysis of four countries across the region based on market assessment, economic development, sociodemographic factors, governance indicators, and technological infrastructure.
Country Deep Dive: Provides the overview, demographic analysis, and key trends across high-potential countries.
Success Stories: This section features some of the most compelling consumer health manufacturers, brands, products, and marketing campaigns in the Western European region. It also provides a better understanding of how certain manufacturers achieved success in the sector.
Competitive Environment: Provides an overview of leading companies in Western Europe, as well as analyzing the growth of private labels in the region.
Distribution Analysis: Provides analysis of the leading distribution channels in the Western European consumer health industry in 2022. It covers nine distribution channels: chemists/pharmacies, parapharmacies/drugstores, e-retailers, direct sellers, hypermarkets & supermarkets, convenience stores, cash & carries & warehouse clubs, “dollar stores”, variety stores & general merchandise retailers, other specialist retailers.
Select Industry Metrics: Provides data for alternative content including patent analytics, job analytics, and deals analytics.
Challenges and Future Outlook: Provides the challenges and outlook pertaining to the Western European consumer health industry.
Scope
- Provides an overview of current consumer health industry scenario regarding the future outlook in terms of ingredients, product claims, labeling, and distribution. The analysis also covers regional overview across five regions - Asia-Pacific, Middle East and Africa, Americas, Western Europe, and Eastern Europe - highlighting industry size, growth drivers, latest developments, and future inhibitors for the regions.
Reasons to Buy
- Manufacturing and retailers seek latest information on how the market is evolving to formulate their sales and marketing strategies. There is also demand for authentic market data with a high level of detail. This report has been created to provide its readers with up-to-date information and analysis to uncover emerging opportunities of growth within the sector in the region
- The report provides a detailed analysis of the countries in the region, covering the key challenges, competitive landscape and demographic analysis, that can help companies gain insight into the country specific nuances
- The analysts have also placed a significant emphasis on the key trends that drive consumer choice and the future opportunities that can be explored in the region, than can help companies in revenue expansion
- To gain competitive intelligence about leading brands in the sector in the region with information about their market share and growth rates
Table of Contents
- Executive Summary
Part 1: Market Environment
Part 2: High-Potential Countries Analysis
Part 3: Country Deep Dive
Part 4: Success Stories
Part 5: Competitive Environment
Part 6: Distribution Analysis
Part 7: Select Industry Metrics
Part 8: Challenges and Future Outlook
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- GSK
- Bayer
- Johnson & Johnson
- Procter & Gamble
- Sanofi-Aventis
- Reckitt Benckiser
- Perrigo Company
- Herbalife International
- STADA Arzneimittel